Teladoc Health, Inc.TDOCNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -3.03% | -2.59% | -1.64% | -2.20% | +0.28% |
| Gross Profit Growth | -3.33% | -4.22% | -2.87% | -4.67% | -1.40% |
| EBITDA Growth | -73.01% | +0.00% | -83.90% | -362.73% | +333.91% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +4.04% | +3.83% | +3.34% | +3.20% | +2.00% |
| Weighted Average Shares Diluted Growth | +4.04% | +3.83% | +3.34% | +2.44% | +2.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -33.96% | +78.46% | +3.10% | -9.90% | +2.14% |
| Free Cash Flow Growth | -56.28% | -301.60% | +3.91% | -14.02% | +51.31% |
| Receivables Growth | -2.65% | +6.75% | +1.76% | -1.82% | -9.96% |
| Inventory Growth | +29.22% | +0.00% | +0.00% | +7.87% | +0.17% |
| Asset Growth | -19.94% | -20.28% | -17.87% | -18.42% | -11.82% |
| Book Value per Share Growth | -38.39% | -39.95% | -8.38% | -10.53% | -8.89% |
| Debt Growth | -0.48% | -0.22% | -34.85% | -34.41% | -34.36% |
| R&D Expense Growth | -33.10% | -14.04% | +5.18% | -37.55% | +245.92% |
| SG&A Expenses Growth | +5.78% | -5.65% | -1.41% | -34.58% | -36.44% |